Andlauer Healthcare Group Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Andlauer Healthcare Group wird voraussichtlich ein Umsatzwachstum verzeichnen at 4.6% per annum.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Healthcare Gewinnwachstum61.1%
Wachstumsrate der Einnahmen4.6%
Zukünftige Eigenkapitalrendite16.3%
Analystenabdeckung

Good

Zuletzt aktualisiert07 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Nov 07
We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Oct 17
Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Sep 20
Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11

Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

May 23
Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Jan 30
These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well

Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Aug 24
Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing

Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

May 05
Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings

Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?

Apr 07
Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?

A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)

Dec 22
A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)

Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns

Dec 09
Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Oct 28
We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Oct 12
These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely

Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

Aug 17
Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return

We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Jul 19
We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

Jul 05
Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt

The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing

May 04
The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing

I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Apr 19
I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease

Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Feb 23
Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?

Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?

Jan 19
Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?

We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger

Jan 06
We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger

Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?

Dec 15
Should You Be Adding Andlauer Healthcare Group (TSE:AND) To Your Watchlist Today?

Gewinn- und Umsatzwachstumsprognosen

TSX:AND - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (CAD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2026719N/A1171553
12/31/2025689N/A1011416
12/31/2024653N/A1001346
9/30/202465166103127N/A
6/30/202464865101125N/A
3/31/20246446585113N/A
12/31/20236486679104N/A
9/30/20236456787116N/A
6/30/20236537194125N/A
3/31/202366576102132N/A
12/31/202264876109137N/A
9/30/2022616110109129N/A
6/30/202255510398111N/A
3/31/2022493958597N/A
12/31/2021440907484N/A
9/30/2021394515461N/A
6/30/2021365475259N/A
3/31/2021328415158N/A
12/31/2020314384651N/A
9/30/2020304316472N/A
6/30/2020299305765N/A
3/31/2020300315461N/A
12/31/2019290305561N/A
9/30/2019285284449N/A
12/31/2018277275052N/A
12/31/201725122N/A43N/A
12/31/201622419N/A30N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von AND über der Sparquote liegt (2.3%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von AND schneller wachsen werden als der Markt Canadian

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von AND in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: ANDDie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Canadian (7% pro Jahr).

Hohe Wachstumseinnahmen: ANDDie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ANDDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (16.3%).


Wachstumsunternehmen entdecken